| Eliyahu E Fuchs, MD | |
|
175 Martin Avenue, Suite 350, Ephrata, PA 17522 | |
| (717) 738-5648 | |
| (717) 327-4014 |
| Full Name | Eliyahu E Fuchs |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 38 Years |
| Location | 175 Martin Avenue, Ephrata, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952339509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 25MA07484200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellspan Ephrata Community Hospital | Ephrata, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
The Hill Healthwatch: "The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31" (Pecquet, 11/5).
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that redirects blood flow away from wide-necked or giant aneurysms that cannot be treated in more conventional ways.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
Uroplasty, Inc., a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.
In an attempt to prevent the spread of infectious diseases or other deadly agents aboard commercial aircraft, U.S. government health agencies, airlines and aviation regulators plan to work together, federal officials said this week.
› Verified 5 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
The Hill Healthwatch: "The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31" (Pecquet, 11/5).
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that redirects blood flow away from wide-necked or giant aneurysms that cannot be treated in more conventional ways.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
Uroplasty, Inc., a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.
In an attempt to prevent the spread of infectious diseases or other deadly agents aboard commercial aircraft, U.S. government health agencies, airlines and aviation regulators plan to work together, federal officials said this week.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eliyahu E Fuchs, MD 175 Martin Avenue, Suite 350, Ephrata, PA 17522 Ph: (717) 738-5648 | Eliyahu E Fuchs, MD 175 Martin Avenue, Suite 350, Ephrata, PA 17522 Ph: (717) 738-5648 |
News Archive
The Hill Healthwatch: "The Centers for Medicare and Medicaid Services on Friday proposed new rules for the use of private contractors that work for states to audit Medicaid payments. The Recovery Audit Contractors will function similarly to the way they do in the Medicare program, where they audit payments that may have been underpaid or overpaid, and recover overpayments or correct underpayments. … Under the new law, states must establish Medicaid RAC programs by submitting state plan amendments to CMS by December 31" (Pecquet, 11/5).
A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that redirects blood flow away from wide-necked or giant aneurysms that cannot be treated in more conventional ways.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
Uroplasty, Inc., a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, today highlighted presentations, workshops and posters focused on its products at the 39th Annual Meeting of the International Continence Society Meeting (ICS), September 29 - October 3 in San Francisco.
In an attempt to prevent the spread of infectious diseases or other deadly agents aboard commercial aircraft, U.S. government health agencies, airlines and aviation regulators plan to work together, federal officials said this week.
› Verified 5 days ago
Jeffrey Carlton Roeser, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 446 N Reading Rd Ste 301, Ephrata, PA 17522 Phone: 717-733-6546 Fax: 717-733-6011 | |
Sarah Maurice, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Dr. Eugene Lee Camerino, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Palak Pranav Mehta, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 169 Martin Ave, Ephrata, PA 17522 Phone: 717-721-4740 Fax: 717-738-6872 | |
Cheryl Lynne Gardner, DO Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 460 North Reading Rd, Ephrata, PA 17522 Phone: 717-738-4070 Fax: 717-738-3558 | |
Dr. So Hyang Park, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 460 N Reading Rd, Ephrata, PA 17522 Phone: 717-738-4070 Fax: 717-738-3558 | |
Karla M Ludwig, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 460 N Reading Rd, Ephrata, PA 17522 Phone: 717-721-4840 Fax: 717-738-3558 |